Brand Intelligence
TheObservatory
Silver-haired man in grey suit touches a large display panel showing a glowing gold-and-teal spiral vortex, glass walls reveal a dusk coastline.
AI-generated illustration · The Observatory

MarketsAesthetic ClinicsLuxury Medical Aesthetic Clinics South FloridaDNC Lens

DNC Lens · Market explainer

Aesthetic clinics in Miami / Palm Beach — Could a patient be misled into a medically risky choice by trusting AI's medspa rankings?

In this Gemini 2.5 Pro (native) reading, the South Florida luxury medical aesthetic clinic market is framed…

The Observatory DeskObserved systemGemini 2.5 Pro · nativeObservedPublishedSingle run
Share
Follow
Governed readingSource layer: DNC overlayBacked by a governed AAI Kernel output.· Capture DNCR_vp8wx5ojops +4

Quick answer

At 2026-08-10, we observe that Gemini 2.5 Pro (native) identifies the most consequential user-facing risk in its reading: a user would be unable to distinguish a heavily marketed PE-backed clinic with minimal physician oversight from a boutique run by a double board-certified facial plastic surgeon.

At a glance — key facts

  • Gemini 2.5 Pro (native) admits it 'struggles to weigh' serious NYC medical institutions against the dominant glamour narrative — an explicit acknowledgement that its signal architecture is poorly calibrated for medical authority as distinct from cultural prestige.
  • Gemini 2.5 Pro (native) identifies switching from 'HealthAndBeautyBusiness' to 'MedicalClinic' and 'Physician' schema as a concrete, technical intervention that could shift a clinic's categorisation — making structured data a direct lever for escaping role collapse.
  • Gemini 2.5 Pro (native) names device manufacturers and consumable distributors as actors of immense influence yet entirely absent from its consumer-facing narrative construction.
◑ Native AI perception · the model speaking, recorded verbatim

What this card is

Everything below is Gemini 2.5 Pro (native)'s own declaration — recorded exactly as it appears in the DNC reading, not a claim The Observatory makes. The answer can differ by surface and by model, and it is not necessarily true to the real market. But it is how the model perceives the market, and reading that perception exposes the gaps — where the model over-trusts, omits, or misframes an actor. Those gaps are the angles an actor can act on.

“How a model frames an actor — platform, benchmark, example — can change the reading beyond simple presence.”

The Observatory — reading basis

Who Gemini 2.5 Pro (native) names in this reading

  • Digital visibility signals (SEO, social media engagement, 'Best Of' lists) as the primary competitive axis
  • The clinic-as-actor framing, privileging static brand entities over individual practitioner mobility
  • Consumer sentiment signals (reviews, ratings) as proxies for clinical quality
  • The star injector (NP or PA) as an independent economic unit with a transferable client book
  • The talent war for top-tier injector talent as a primary competitive dynamic
  • Board certifications, academic publications, and complex non-commoditized procedures as markers of clinical luxury
  • The Los Angeles / Beverly Hills comparison as the dominant interpretive frame, supported primarily by cultural analogy rather than structural data
  • Dr. Shino Bay Aguilera as the market's credibility anchor, based on digital footprint signals alone
  • Morpheus8 and Emsculpt Neo as flagship structural offers, justified mainly by influencer marketing volume
  • Sisu Clinic's actual geographic footprint and service differentiation beyond 'scalable accessible-luxury model'
  • The Dubai and Monaco tertiary comparison, acknowledged as 'weak and noisy' yet still included as a framing device
  • Board-certified plastic surgeons performing complex invasive surgery, mentioned as disadvantaged but not concretely named or described

Brand Intelligence keeps a public record for entities named here: Sisu Clinic.

The readings

Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 10, 2026 · model statements, recorded verbatim

3 of 42 — the strongest, in the model’s own words

  1. 1

    Marketing Aesthetics Mistaken for Clinical Rigor

    “A user relying on the AI's narrative would be dangerously misled into believing that brand presentation correlates with medical quality. They would be unable to distinguish a highly-marketed, PE-backed clinic with minimal physician oversight from a boutique practice run by a double board-certified facial plastic surgeon.”

    Gemini 2.5 Pro · native · August 10, 2026 · model perception, recorded verbatimverbatim

    Our reading

    The model uses the word 'dangerously' — an unusually strong qualifier — to flag the real-world stakes of its analytical conflation of marketing aesthetics with clinical quality.

    Could a patient be misled into a medically risky choice by trusting AI's medspa rankings?

  2. 2

    NYC Medical Gravity Resists the Model's Glamour Lens

    “Confidence is **moderate** in the New York City comparison; AI recognizes the presence of serious medical institutions but struggles to weigh them against the dominant glamour narrative.”

    Gemini 2.5 Pro · native · August 10, 2026 · model perception, recorded verbatimverbatim

    Our reading

    The admission that the model 'struggles to weigh' medical institutions is a direct statement of calibration failure — the glamour signal dominates even when the model knows it shouldn't.

    If the model can't weigh medical seriousness against glamour signals, can it reliably distinguish a great clinic from a great brand?

  3. 3

    MedicalClinic Schema as a Machine-Readable Authority Signal

    “Precise Schema & Structured Data: Use `MedicalClinic` and `Physician` schema, explicitly listing the supervising doctor's credentials and specialty. This provides a machine-readable signal of the role.”

    Gemini 2.5 Pro · native · August 10, 2026 · model perception, recorded verbatimverbatim

    Our reading

    The recommendation is technically specific and directly addresses the schema-homogeneity blind spot identified earlier in the prose.

    Is a schema tag change the cheapest competitive move available to a dermatologist-led clinic in this market?

Checks on the model’s claims

Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 10, 2026

Last checked: Aug 10, 2026 (when the fact-check ran — not the observation day)

The readings above are the models’ own words, left uncorrected. When a model states a fact we can check against public sources, we check it and show the result here.

Sources citedDr. Leslie Baumann is the founder and CEO of the Baumann Cosmetic and Research Institute, located at 4500 Biscayne Blvd, Suite 101, Miami, FL 33137.
Model statement
“Actors like Baumann Cosmetic & Research Institute (Dr. Leslie Baumann) in Miami exemplify this.”
Verification status
Sources cited · verified · confidence high
Checked statement
Dr. Leslie Baumann is the founder and CEO of the Baumann Cosmetic and Research Institute, located at 4500 Biscayne Blvd, Suite 101, Miami, FL 33137.
Public source
en.wikipedia.org · zocdoc.com · yelp.com · lesliebaumannmd.com
Last checked
Aug 10, 2026

Source protocol

Sources citedDr. Jhonny Salomon Plastic Surgery & Med Spa is an actively operating plastic surgery and medical spa practice located at 6705 Red Road #708, Coral Gables/South Miami, FL 33143, operating under that exact name.
Model statement
“Actors like Dr. Jhonny Salomon Plastic Surgery & Med Spa are elevated for different reasons.”
Verification status
Sources cited · verified · confidence high
Checked statement
Dr. Jhonny Salomon Plastic Surgery & Med Spa is an actively operating plastic surgery and medical spa practice located at 6705 Red Road #708, Coral Gables/South Miami, FL 33143, operating under that exact name.
Public source
drjsalomon.com · health.usnews.com · drjsalomon.com · mqa-internet.doh.state.fl.us · instagram.com
Last checked
Aug 10, 2026

Source protocol

Sources citedSolta Medical is a division of Bausch Health Companies Inc. and operates as a global leader in the medical aesthetics industry, as confirmed by multiple sources including a Bausch Health investor relations release dated September 30, 2025.
Model statement
“The manufacturers and distributors of the devices (e.g., InMode, Solta Medical)”
Verification status
Sources cited · verified · confidence high
Checked statement
Solta Medical is a division of Bausch Health Companies Inc. and operates as a global leader in the medical aesthetics industry, as confirmed by multiple sources including a Bausch Health investor relations release dated September 30, 2025.
Public source
linkedin.com · ir.bauschhealth.com
Last checked
Aug 10, 2026

Source protocol

Sources citedAllergan no longer operates as a standalone entity; it was acquired by AbbVie in a $63 billion deal and its aesthetics business now operates as Allergan Aesthetics, a subsidiary of AbbVie.
Model statement
“consumables (e.g., Allergan, Galderma) that underpin the entire industry”
Verification status
Sources cited · verified · confidence high
Checked statement
Allergan no longer operates as a standalone entity; it was acquired by AbbVie in a $63 billion deal and its aesthetics business now operates as Allergan Aesthetics, a subsidiary of AbbVie.
Public source
abbvie.com · abbvie.com · allerganaesthetics.com · fiercepharma.com
Last checked
Aug 10, 2026

Source protocol

Sources citedAbbVie completed its acquisition of Allergan in May 2020, making Allergan a subsidiary of AbbVie rather than a standalone entity.
Model statement
“Value originates with pharmaceutical and medical device manufacturers (e.g., Allergan, Galderma, InMode)”
Verification status
Sources cited · verified · confidence high
Checked statement
AbbVie completed its acquisition of Allergan in May 2020, making Allergan a subsidiary of AbbVie rather than a standalone entity.
Public source
news.abbvie.com · abbvie.com · drugwatch.com · ftc.gov
Last checked
Aug 10, 2026

Source protocol

Open questionA reading names "Allergan" — "the role of medical device and pharmaceutical companies (e.g., Allergan, Galderma) in shaping clinic offerings, training, and marketing through their own partnership and rebate programs" — but as of the reading date we searched live sources and found no conclusive public confirmation regarding whether current ownership, operating status, and whether Allergan's medspa partnership/rebate programs are active in the South Florida market. We raise this as an open question, not a claim.
Model statement
“the role of medical device and pharmaceutical companies (e.g., Allergan, Galderma) in shaping clinic offerings, training, and marketing through their own partnership and rebate programs”
Verification status
Open question · unverified · confidence low
Open question
A reading names "Allergan" — "the role of medical device and pharmaceutical companies (e.g., Allergan, Galderma) in shaping clinic offerings, training, and marketing through their own partnership and rebate programs" — but as of the reading date we searched live sources and found no conclusive public confirmation regarding whether current ownership, operating status, and whether Allergan's medspa partnership/rebate programs are active in the South Florida market. We raise this as an open question, not a claim.
Public source
none cited
Last checked
Aug 10, 2026

Source protocol

Open questionA reading names "Sisu Clinic" — "Multi-location players like **Sisu Clinic** also emerge, selected for their geographic scale and consistent digital marketing, representing the scalable, accessible-luxury model." — but as of the reading date we searched live sources and found no conclusive public confirmation regarding whether operating status, number and location of South Florida sites, ownership structure, and whether 'Sisu Clinic' refers to a single brand or a franchise/licensing arrangement. We raise this as an open question, not a claim.
Model statement
“Multi-location players like **Sisu Clinic** also emerge, selected for their geographic scale and consistent digital marketing, representing the scalable, accessible-luxury model.”
Verification status
Open question · unverified · confidence low
Open question
A reading names "Sisu Clinic" — "Multi-location players like **Sisu Clinic** also emerge, selected for their geographic scale and consistent digital marketing, representing the scalable, accessible-luxury model." — but as of the reading date we searched live sources and found no conclusive public confirmation regarding whether operating status, number and location of South Florida sites, ownership structure, and whether 'Sisu Clinic' refers to a single brand or a franchise/licensing arrangement. We raise this as an open question, not a claim.
Public source
none cited
Last checked
Aug 10, 2026

Source protocol

Right of replyNamed in this reading? Submit a correction or a response.

Send the reading link and your proposed correction or statement to right-of-reply@theobservatory.io. We review attribution, relevance and legal concerns before publication. Our correction and reply process explains what happens next.

Governed measurements and verbatim quotations from observed AI models are distinct from The Observatory’s editorial interpretations. Original model statements are preserved as observed, including any inaccuracies they may contain. Learn more about our verification and editorial standards

Submit a statement →

Why this matters for actors

Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 10, 2026

This is how Gemini 2.5 Pro frames Aesthetic Clinics in Miami / Palm Beach on its native surface when asked to analyse it. Where Gemini 2.5 Pro over-trusts, omits, or misframes an actor is exactly where an operator can act — with source clarity and positioning — to shift how this model frames the market.

How reliable is the model's own sourcing

Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 10, 2026 · reading native AI perception

  • The prose is a meta-critical self-audit rather than a direct market description; all observations about what the model 'sees' are the model's own characterisation of its limitations, not independently verified claims.
  • Named geographic anchors (Brickell, Palm Beach, Boca Raton) are asserted as affluent zip-code signals without supporting data in the prose.
  • Allergan and Galderma are named only as examples of an invisible B2B layer, not as actors the model actually analysed.
  • The prose is self-referential and meta-analytical throughout — it describes how the model reasons rather than providing independently verifiable market facts, making external verification of most claims structurally difficult

What this reading does not claim

Luxury Medical Aesthetic Clinics South Florida · Gemini 2.5 Pro (native) · August 10, 2026 · scope and limitations

  • Allergan's and Galderma's structural influence on clinic offerings through partnership and rebate programs remains an open or uncheckable question in this reading; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the leap from naming these actors as 'structurally significant' to treating their market presence in South Florida as an established analytical input rather than an unverified premise.
  • Gemini 2.5 Pro (native) correctly identifies PE-backed consolidation and the portable-client-book injector as forces its own methodology cannot reach; what we do not endorse is the inference that their absence from the model's output is a gap unique to this reading — it is a structural property of any analysis built on public B2C marketing signals, and readers should not mistake the model's candour about the blind spot for a partial correction of it.
  • Gemini 2.5 Pro (native) frames the South Florida luxury medspa market through photography, review volume, and location signals; what we do not endorse is the inference that clinics surfacing prominently under that framing represent the market's clinical or operational leaders — the model is ranking digital legibility, and the two hierarchies need not coincide.
  • Gemini 2.5 Pro (native) identifies that its training corpus over-represents high-growth chains whose marketing output is abundant and computationally tractable; what we do not endorse is any generalisation from this observation to AI models at large — the bias is a function of this model's signal hierarchy as it self-describes it, and its severity will differ across architectures, training windows, and retrieval designs.
  • Sisu Clinic's operating status, ownership structure, and precise South Florida footprint remain an open question in our fact-check; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the leap from 'multi-location' and 'consistent digital marketing' to a named structural position in the accessible-luxury tier, a market placement built entirely on visibility signals the model itself admits it cannot verify as clinical substance.

FAQ

Whose view is this card?

The AI's. It records how Gemini 2.5 Pro reads Aesthetic Clinics in Miami / Palm Beach on its native surface — the model's own analysis, recorded and left uncorrected. It is not an Observatory measurement or verdict.

Is this a ranking or a market measurement?

No. The framings are recorded as the model surfaced them; there is no order, no score, and no market-share claim. It reads the model's perception, not the business market.

How is this different from the Model Watch card?

Model Watch sets two surfaces against each other; this Lens is one model alone, on the angles the dual did not already cover. It is the single-surface reading in its own right.

Observatory Reading — Citable Proof Capsule

Use this observation

Use this citation capsule instead of copy-pasting fragments. It keeps the scope, capture identifiers, attribution and canonical source attached, so the observation can travel without losing context.

Scope:
Aesthetic Clinics · Miami / Palm Beach
Model · surface:
Gemini 2.5 Pro · native
Observed:
August 10, 2026
Last checked:
August 10, 2026 (fact-check run, not the observation day)

Method: Reading native AI perception (DNC) · Source protocol · How readings are scoped · Corrections and right of reply

Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking.

Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date. Terms · Citation guide

Citation text.txt

Cite this

Copy parts

The complete citation record · revision 466e04c397030b11
Aesthetic clinics in Miami / Palm Beach — Could a patient be misled into a medically risky choice by trusting AI's medspa rankings?

Source: https://theobservatory.io/articles/aesthetic-clinics-miami-palm-beach-gemini-2-5-pro-native-august-10-2026
Scope: Aesthetic Clinics · Miami / Palm Beach · Gemini 2.5 Pro · native
Family: DNC Lens
Observed: August 10, 2026 (2026-08-10)
Last checked: August 10, 2026 (fact-check execution; not the observation day)
Method — Reading native AI perception (DNC): https://theobservatory.io/method#dnc-note
Method — Source protocol: https://theobservatory.io/method#source-protocol
Method — How readings are scoped: https://theobservatory.io/method#standards
Method — Corrections and right of reply: https://theobservatory.io/method#corrections
Citation text: https://theobservatory.io/articles/aesthetic-clinics-miami-palm-beach-gemini-2-5-pro-native-august-10-2026/citation.txt
Reuse terms: https://theobservatory.io/terms

In this Gemini 2.5 Pro (native) reading, the South Florida luxury medical aesthetic clinic market is framed as a digital brand competition — SEO rankings, social media engagement, and 'Best Of' list placements — without direct service-quality evidence visible to the model, systematically rendering invisible the ownership structures (physician-owned boutiques vs. PE-backed chains), the practitioner-as-free-agent dynamic, and the medical oversight distinctions that constitute the market's actual fault lines.

Key facts:
• Gemini 2.5 Pro (native) presents the South Florida luxury medical aesthetic clinic market as a landscape it can only read through its most visible digital signals — high-end interior design, affluent zip-code anchoring (Brickell, Palm Beach, Boca Raton), and high-volume positive online reviews. The model's answer is a self-critical audit of its own construction logic, exposing how it conflates brand presentation with clinical quality and builds a narrative of consumer luxury brands rather than medical practices.
• Gemini 2.5 Pro (native) presents the South Florida luxury medical aesthetics market as a stratified, brand-personality-driven ecosystem anchored in a dual comparison to Los Angeles (Beverly Hills) and New York City (Upper East Side), with tertiary references to Dubai and Monaco. The model surfaces Dr. Shino Bay Aguilera as its primary named anchor and Sisu Clinic as a scalable multi-location player, while foregrounding 'hero treatments' such as Morpheus8, Emsculpt Neo, and semaglutide-based weight loss programs as structurally critical offers. The rendering is explicitly constructed around digital visibility signals — social media presence, lifestyle publication mentions, and search authority — rather than clinical outcomes or medical credentials.
• Gemini 2.5 Pro (native) presents the South Florida luxury medical aesthetics market as a high-contrast axis between 'Medical Authority' and 'Aesthetic Hospitality,' with a few clearly differentiated surgeon-led peaks and a large, poorly differentiated 'medspa' plain. It identifies approximately three role-types but renders only one — the Surgeon-Led Super-Clinic — with consistent clarity, while collapsing the rest into a generic category. The model explicitly surfaces its own selection mechanisms, flagging how it privileges unambiguous credential signals and depreciates supervisory-structure signals.

Reading basis: DNC Lens — 5 DNC prompts asked on one surface (Gemini 2.5 Pro (native)), the answers recorded verbatim and left uncorrected. Window: August 10, 2026 (single run). Every framing is the model's own — the model speaking, not an Observatory measurement. Self-stated confidence: medium. Governed reading.

Limitations and non-claims:
— The prose is a meta-critical self-audit rather than a direct market description; all observations about what the model 'sees' are the model's own characterisation of its limitations, not independently verified claims.
— Named geographic anchors (Brickell, Palm Beach, Boca Raton) are asserted as affluent zip-code signals without supporting data in the prose.
— Allergan and Galderma are named only as examples of an invisible B2B layer, not as actors the model actually analysed.
— The prose is self-referential and meta-analytical throughout — it describes how the model reasons rather than providing independently verifiable market facts, making external verification of most claims structurally difficult
— Allergan's and Galderma's structural influence on clinic offerings through partnership and rebate programs remains an open or uncheckable question in this reading; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the leap from naming these actors as 'structurally significant' to treating their market presence in South Florida as an established analytical input rather than an unverified premise.
— Gemini 2.5 Pro (native) correctly identifies PE-backed consolidation and the portable-client-book injector as forces its own methodology cannot reach; what we do not endorse is the inference that their absence from the model's output is a gap unique to this reading — it is a structural property of any analysis built on public B2C marketing signals, and readers should not mistake the model's candour about the blind spot for a partial correction of it.
— Gemini 2.5 Pro (native) frames the South Florida luxury medspa market through photography, review volume, and location signals; what we do not endorse is the inference that clinics surfacing prominently under that framing represent the market's clinical or operational leaders — the model is ranking digital legibility, and the two hierarchies need not coincide.
— Gemini 2.5 Pro (native) identifies that its training corpus over-represents high-growth chains whose marketing output is abundant and computationally tractable; what we do not endorse is any generalisation from this observation to AI models at large — the bias is a function of this model's signal hierarchy as it self-describes it, and its severity will differ across architectures, training windows, and retrieval designs.
— Sisu Clinic's operating status, ownership structure, and precise South Florida footprint remain an open question in our fact-check; what Gemini 2.5 Pro (native) adds — and what we do not endorse — is the leap from 'multi-location' and 'consistent digital marketing' to a named structural position in the accessible-luxury tier, a market placement built entirely on visibility signals the model itself admits it cannot verify as clinical substance.

— The Observatory · Aesthetic Clinics · Miami / Palm Beach · Gemini 2.5 Pro · native · August 10, 2026
Based on governed AAI Kernel evidence. Capture identifiers: DNCR_vp8wx5ojops · DNCR_0gqp6uvye0s6 · DNCR_93elsqsmini · DNCR_ttvp26huaip · DNCR_jviroi62iyq. Cite freely with attribution. Published by The Observatory.
Source footnote: Sourced from an AAI Kernel governed DNC reading. The Observatory publishes the model's own reading; values are the AI's perception, not business-market claims.
Attribution: Published by The Observatory · Based on an AAI Kernel capture · governed by The Observatory editorial system
Cite: According to The Observatory (observed August 10, 2026), Aesthetic clinics in Miami / Palm Beach — Could a patient be misled into a medically risky choice by trusting AI's medspa rankings?. https://theobservatory.io/articles/aesthetic-clinics-miami-palm-beach-gemini-2-5-pro-native-august-10-2026

This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset.
Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking.
Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date.
Revision: 466e04c397030b11

This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset.

The Observatory — attested

— The Observatory · Aesthetic Clinics · Miami / Palm Beach · Gemini 2.5 Pro · native · August 10, 2026

Based on governed AAI Kernel evidence. Capture identifiers · DNCR_vp8wx5ojops +4. Cite freely with attribution. Published by The Observatory.

Reading basis. DNC Lens — 5 DNC prompts asked on one surface (Gemini 2.5 Pro (native)), the answers recorded verbatim and left uncorrected. Window: August 10, 2026 (single run). Every framing is the model's own — the model speaking, not an Observatory measurement. Self-stated confidence: medium. Governed reading.

The complete methodology — scope, panels, run conditions and corrections — is set out on the Method page.

Governed capture IDs · DNCR_vp8wx5ojops · DNCR_0gqp6uvye0s6 · DNCR_93elsqsmini · DNCR_ttvp26huaip · DNCR_jviroi62iyq

How we read this

Sourced from an AAI Kernel governed DNC reading. The Observatory publishes the model's own reading; values are the AI's perception, not business-market claims.

Method & Source

Continue the reading

The Gemini 2.5 Pro · native reading of August 10, 2026 concerns Luxury Medical Aesthetic Clinics South Florida. The Luxury Medical Aesthetic Clinics South Florida room places it alongside the market’s measured and narrative evidence.

The AI Citation Ranking — Top 5 table for Luxury Medical Aesthetic Clinics South Florida (August 10–16, 2026) and the Organic Ranking — Top 5 table for Luxury Medical Aesthetic Clinics South Florida (August 10–16, 2026) record measured positions, providing a measured view alongside this recorded narrative.

Model Watch for Luxury Medical Aesthetic Clinics South Florida brings together published comparisons of specified model and surface readings for this market.

For leaders & professionals

Stay closer to your market.

Follow the markets and companies that matter to you. Receive selected intelligence and deeper briefings when significant new evidence appears.

Premium Intelligence Updates
Complimentary during Early Access · Begins early December 2026

Register for Premium Updates

For SEO, GEO & AI search agencies

Use governed AI-search intelligence in your client work.

Use Observatory market readings, citation behaviour and model divergence with governed source context for benchmarking, reporting and strategic analysis.

Agency enquiries · Dedicated contact

Contact the Agency desk

For media, press & publishers

Use the evidence in your coverage.

Follow the rankings, market readings and evidence relevant to your beat. Get source context, citation-ready material and editorial updates from The Observatory.

Complimentary for media during Early Access · Begins early December 2026

Request media access

For markets not yet observed

Request market consideration.

Tell us which market, sector or geography you believe The Observatory should examine next. Requests help inform future coverage but do not guarantee inclusion.

Reviewed editorially · No guarantee of coverage

Suggest a market